The application of health technology assessment in osteoporosis

J.A. Kanis*, M. Hiligsmann

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Because of the high costs to patients, health care payers and to society, it is important to allocate healthcare resources appropriately and efficiently. Health technology assessment aims to evaluate the clinical, economic, social, and ethical implications of a disease, and its prevention and treatment to guide national healthcare policies (e.g. clinical and research investment, reimbursement decisions). In this chapter, we review the various aspects of health technology assessment in osteoporosis, including epidemiology and burden of disease, and assessment of the cost-effectiveness of the treatment of osteoporosis and the prevention of fracture. Health technology assessment indicates an immense burden of osteoporotic fractures for patients and society that is set to increase as the number of elderly people increases. Prevention and treatment of osteoporosis have been shown to be a cost-effective way of allocating scarce healthcare resources.

Original languageEnglish
Pages (from-to)895-910
Number of pages16
JournalBest Practice & Research Clinical Endocrinology & Metabolism
Volume28
Issue number6
DOIs
Publication statusPublished - Dec 2014

Keywords

  • burden of disease
  • cost-effectiveness
  • economic evaluation
  • health technology assessment
  • osteoporosis
  • treatment
  • QUALITY-OF-LIFE
  • COST-EFFECTIVENESS
  • ECONOMIC-EVALUATION
  • POSTMENOPAUSAL WOMEN
  • STRONTIUM RANELATE
  • INTERVENTION THRESHOLDS
  • ORAL BISPHOSPHONATES
  • MEDICATION ADHERENCE
  • DECISION-MAKING
  • SOCIETAL BURDEN

Cite this